Table 3.
Oral Iron | IV Iron | |
---|---|---|
Choice of administration | Mild IDA (Hb > 100 g/L) Quiescent IBD |
Severe anaemia (Hb < 100 g/L) Intolerant to oral iron Moderate to severe IBD activity |
Pros | Greater availability Ease of administration Low cost |
Bypasses GI tract absorption Less side effects |
Cons | Side effects with poor patient tolerance Discontinuation in 20% Increases IBD activity Disrupts microbiome |
Low bioavailability Inconvenience of IV application Greater cost Risk of hypersensitivity reaction * |
* Hypersensitivity risk rare in LMW (low molecular weight) dextran and newer IV formulations. IDA: iron deficiency anaemia; GI: gastrointestinal; Hb: haemoglobin; IBD: inflammatory bowel disease.